Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $25.10 USD
Change Today -0.80 / -3.09%
Volume 213.7K
KPTI On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Giulio Draetta M.D., Ph.D.

Chairman of Scientific Advisory Board, Karyopharm Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 67 board members in 5 different organizations across 5 different industries.

See Board Relationships
----

Background*

Dr. Giulio Draetta, M.D., PhD serves as Director, Institute for Applied Cancer Science, Professor of Genomic Medicine and Professor of Molecular and Cellular Oncology at The University of Texas MD Anderson Cancer Center. Dr. Draetta is a co-founder of Karyopharm, which develops inhibitors of nuclear transport targets for the treatment of cancer and other diseases. Dr. Draetta served as Chief Research Business Development Officer at Dana Farber Cancer Institute (DFCI). ...

Read Full Background

Corporate Headquarters*

85 Wells Avenue
Newton, Massachusetts 02459

United States

Phone: 617-658-0600
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Universita' degli Studi di Napoli Federico II
Post-Doctoral Training
Universita' degli Studi di Napoli Federico II
MD
Universita' degli Studi di Napoli Federico II

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KPTI:US $25.10 USD -0.80

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KARYOPHARM THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.